SYRS - Syros Pharmaceuticals Inc. (SYRS) Q2 2024 Earnings Call Transcript
2024-07-31 11:10:23 ET
Syros Pharmaceuticals, Inc. (SYRS)
Q2 2024 Earnings Conference Call
July 31, 2024 08:30 AM ET
Company Participants
Karen Hunady - Director of Investor Relations and Corporate Communications
Conley Chee - President and Chief Executive Officer
David Roth - Chief Medical Officer
Jason Haas - Chief Financial Officer
Conference Call Participants
Philip Nadeau - TD Cowen
Ted Tenthoff - Piper Sandler
Roy Buchanan - Citizens JMP
Leah Cann - Brookline Capital Markets
Presentation
Operator
Good morning, and welcome to Syros Pharmaceuticals Second Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors & Media section of Syros website at www.syros.com. Please be advised that today's call is being recorded.
At this time, I would like to turn the call over to Karen Hunady, Director of Investor Relations and Corporate Communications at Syros. Please go ahead.
Karen Hunady
Thank you. This morning, we issued a press release announcing our second quarter 2024 financial results. The full release is available on the Investor & Media section of Syros' website at www.syros.com....
Syros Pharmaceuticals, Inc. (SYRS) Q2 2024 Earnings Call Transcript